AC Immune SA (ACIU) stock
ACIUNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.13+0.03 (+1.43%)
Close on Nov 19, 2026Market cap $216.71MP/E –Yield –
AC Immune free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
AC Immune's free cash flow for the twelve months ending Dec 31, 2022 was -CHF 74.81M. For fiscal 2025 it was -CHF 70.16M, down 207.5% from the year before. The highest annual figure on record is CHF 65.27M in fiscal 2024.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -CHF 70.16M | -207.5% |
| FY2024 | Dec 31, 2024 | CHF 65.27M | – |
| FY2023 | Dec 31, 2023 | -CHF 61.21M | – |
| FY2022 | Dec 31, 2022 | -CHF 74.81M | – |
| FY2021 | Dec 31, 2021 | -CHF 68.32M | – |
| FY2020 | Dec 31, 2020 | -CHF 61.22M | -214.8% |
| FY2019 | Dec 31, 2019 | CHF 53.34M | – |
| FY2018 | Dec 31, 2018 | -CHF 45.94M | – |
| FY2017 | Dec 31, 2017 | -CHF 23.90M | – |
| FY2016 | Dec 31, 2016 | -CHF 6.55M | -114.9% |
| FY2015 | Dec 31, 2015 | CHF 43.84M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2022 | Dec 31, 2022 | -CHF 17.45M | – |
| Q3 FY2022 | Sep 30, 2022 | -CHF 13.66M | – |
| Q4 FY2021 | Dec 31, 2021 | -CHF 18.55M | – |
See a number that looks wrong?